Europe Animal Healthcare Market, By Animal Type (Livestock Animals and Companion Animal), By Route of Administration (Oral, Topical, and Injectable), By Indication (Infectious Disease, Pain, Autoimmune Disease, and Others), and by Country (U.K., Germany,

Europe Animal Healthcare Market, By Animal Type (Livestock Animals and Companion Animal), By Route of Administration (Oral, Topical, and Injectable), By Indication (Infectious Disease, Pain, Autoimmune Disease, and Others), and by Country (U.K., Germany, France, Spain, Russia, Switzerland, Netherlands, Italy, and Rest of Europe) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Animal healthcare include veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics and parasiticides, which are used in the treatment of disease associated with digestive system, immunological system, reproductive system, respiratory, and urinary system of animals. Rapid increase in zoonotic viral diseases and other animal-borne diseases can have adverse effects on farming and other occupation. Efficient animal healthcare can facilitate enhanced productivity of livestock to the farmers, as livestock animals provide major protein source through meat and milk. Increasing public-private collaboration to increase awareness about efficient animal healthcare in Europe is expected to drive growth of the Europe animal healthcare market.
Market Dynamics
Market players are focused on investments in research and development activities in order to strengthen their market presence in Europe, and to develop novel products to prevent diseases in livestock and pets. For instance, in May 2021, Boehringer Ingelheim collaborated with the Veterinary Oncology Advisory Board (VOAB) comprising experts in veterinary oncology from the U.S., Europe, and Japan to develop therapeutic veterinary solutions. Moreover, in 2018, Boehringer Ingelheim invested US$ 220 million for the development of a production center for veterinary public health in French Rhône-Alpes region, also known as the European vaccine valley.
Companies and their subsidiaries operating in Europe region intend to leverage their proprietary technologies for the development of novel therapeutics to treat serious medical conditions in animals. For instance, in April 2021, Interporc, a Spain-based pork board unveiled a new certified animal welfare seal, IAWS, to endorse good practices that will increase demand for animal healthcare, and drive the market growth.
Key features of the study:
This report provides in-depth analysis of the Europe animal healthcare market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Europe animal healthcare market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc, Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
The Europe animal healthcare market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe animal healthcare market
Detailed Segmentation:
Europe Animal Healthcare Market, By Animal Type:
Herbal Extracts
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
Europe Animal Healthcare Market, By Route of Administration:
Memory Enhancement
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
Europe Animal Healthcare Market, By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Europe Animal Healthcare Market, By Country:
U.K.
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Germany
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
France
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Spain
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Russia
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Switzerland
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Netherlands
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Italy
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Rest of Europe
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Company Profiles
Merck & Co., Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Virbac
Dechra Pharmaceuticals Plc
Vetoquinol S.A.
Zoetis Inc.
Ceva Santé Animale
Bayer AG
Elanco
Evonik Industries AG
Archer Daniels Midland Company
“*” marked represents similar segmentation in other categories in the respective section.